fentanyl actavis forðaplástur 100 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 100 míkróg/klst.
fentanyl actavis forðaplástur 25 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 25 míkróg/klst.
fentanyl actavis forðaplástur 50 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 50 míkróg/klst.
fentanyl actavis forðaplástur 75 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 75 míkróg/klst.
potactasol
actavis group ptc ehf - tópótecan - uterine cervical neoplasms; small cell lung carcinoma - Æxlishemjandi lyf - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5. tópótecan ásamt cisplatíni er ætlað fyrir sjúklinga með krabbamein í legháls endurtekin eftir geislameðferð og fyrir sjúklinga með stigi ivb sjúkdómur. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.
oxikodon depot actavis forðatafla 20 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 20 mg
oxikodon depot actavis forðatafla 40 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 40 mg
oxikodon depot actavis forðatafla 10 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 10 mg
oxikodon depot actavis forðatafla 5 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 5 mg
stesolid endaþarmslausn 5 mg/2,5 ml
actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 5 mg/2,5 ml